These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22294808)

  • 1. CSF levels of hypocretin-1 (orexin-A) peak during early infancy in humans.
    Aran A; Shors I; Lin L; Mignot E; Schimmel MS
    Sleep; 2012 Feb; 35(2):187-91. PubMed ID: 22294808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging role of hypocretin (orexin-A) in the developing central nervous system.
    Kotagal S
    Sleep; 2012 Feb; 35(2):171-2. PubMed ID: 22294804
    [No Abstract]   [Full Text] [Related]  

  • 3. CSF orexin-A/hypocretin-1 concentrations in patients with intracerebral hemorrhage (ICH).
    Dohi K; Ripley B; Fujiki N; Ohtaki H; Yamamoto T; Goto Y; Nakamachi T; Shioda S; Aruga T; Nishino S
    Regul Pept; 2008 Jan; 145(1-3):60-4. PubMed ID: 17868933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy.
    Andlauer O; Moore H; Hong SC; Dauvilliers Y; Kanbayashi T; Nishino S; Han F; Silber MH; Rico T; Einen M; Kornum BR; Jennum P; Knudsen S; Nevsimalova S; Poli F; Plazzi G; Mignot E
    Sleep; 2012 Sep; 35(9):1247-55F. PubMed ID: 22942503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocretin-1 (orexin-A) levels in human lumbar CSF in different age groups: infants to elderly persons.
    Kanbayashi T; Yano T; Ishiguro H; Kawanishi K; Chiba S; Aizawa R; Sawaishi Y; Hirota K; Nishino S; Shimizu T
    Sleep; 2002 May; 25(3):337-9. PubMed ID: 12003164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
    Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H
    Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low cerebrospinal fluid hypocretin levels during sudden infant death syndrome (SIDS) risk period.
    Lancien M; Inocente CO; Dauvilliers Y; Kugener B; Scholz S; Raverot V; Lin JS; Guyon A; Gustin MP; Franco P
    Sleep Med; 2017 May; 33():57-60. PubMed ID: 28449906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid hypocretin-1 levels during the active period of cluster headache.
    Cevoli S; Pizza F; Grimaldi D; Nicodemo M; Favoni V; Pierangeli G; Valko PO; Baumann CR; Montagna P; Bassetti CL; Cortelli P
    Cephalalgia; 2011 Jun; 31(8):973-6. PubMed ID: 21444644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypocretin and human African trypanosomiasis.
    Dauvilliers Y; Bisser S; Chapotot F; Vatunga G; Cespuglio R; Josenando T; Buguet A
    Sleep; 2008 Mar; 31(3):348-54. PubMed ID: 18363311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls.
    Nishino S; Sakurai E; Nevsimalova S; Yoshida Y; Watanabe T; Yanai K; Mignot E
    Sleep; 2009 Feb; 32(2):175-80. PubMed ID: 19238804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locomotor-dependent and -independent components to hypocretin-1 (orexin A) regulation in sleep-wake consolidating monkeys.
    Zeitzer JM; Buckmaster CL; Lyons DM; Mignot E
    J Physiol; 2004 Jun; 557(Pt 3):1045-53. PubMed ID: 15107479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia.
    Liguori C; Romigi A; Mercuri NB; Nuccetelli M; Izzi F; Albanese M; Sancesario G; Martorana A; Sancesario GM; Bernardini S; Marciani MG; Placidi F
    J Neurol; 2014 Sep; 261(9):1832-6. PubMed ID: 25119837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.
    Mignot E; Lammers GJ; Ripley B; Okun M; Nevsimalova S; Overeem S; Vankova J; Black J; Harsh J; Bassetti C; Schrader H; Nishino S
    Arch Neurol; 2002 Oct; 59(10):1553-62. PubMed ID: 12374492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions.
    Ripley B; Overeem S; Fujiki N; Nevsimalova S; Uchino M; Yesavage J; Di Monte D; Dohi K; Melberg A; Lammers GJ; Nishida Y; Roelandse FW; Hungs M; Mignot E; Nishino S
    Neurology; 2001 Dec; 57(12):2253-8. PubMed ID: 11756606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status.
    Krahn LE; Pankratz VS; Oliver L; Boeve BF; Silber MH
    Sleep; 2002 Nov; 25(7):733-6. PubMed ID: 12405608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Niemann-Pick disease type C: cataplexy and hypocretin in cerebrospinal fluid.
    Oyama K; Takahashi T; Shoji Y; Oyamada M; Noguchi A; Tamura H; Takada G; Kanbayashi T
    Tohoku J Exp Med; 2006 Jul; 209(3):263-7. PubMed ID: 16778374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal CSF hypocretin-1 (orexin A) levels in dementia with Lewy bodies associated with excessive daytime sleepiness.
    Baumann CR; Dauvilliers Y; Mignot E; Bassetti CL
    Eur Neurol; 2004; 52(2):73-6. PubMed ID: 15256827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of hypocretin (orexin) deficiency in hypocretin/ataxin-3 transgenic rats.
    Zhang S; Lin L; Kaur S; Thankachan S; Blanco-Centurion C; Yanagisawa M; Mignot E; Shiromani PJ
    Neuroscience; 2007 Aug; 148(1):34-43. PubMed ID: 17618058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between hypocretin-1 and amyloid-β42 cerebrospinal fluid levels in Alzheimer's disease and healthy controls.
    Slats D; Claassen JA; Lammers GJ; Melis RJ; Verbeek MM; Overeem S
    Curr Alzheimer Res; 2012 Dec; 9(10):1119-25. PubMed ID: 22742854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular cerebrospinal fluid hypocretin-1 inversely correlates with glucose levels in cerebrospinal fluid and serum from patients with neurological injuries.
    Doherty MJ; Watson NF; Hallam DK; Chandler WL; Longstreth WT
    Neurocrit Care; 2005; 3(3):230-3. PubMed ID: 16377834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.